Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-972-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
A bacterial reverse mutation (Ames) test was performed according to OECD guideline 471. The test substance was not mutagenic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The experimental start date was 04 May 2018 and the experimental completion date was 22 May 2018.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 31 May 2008
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: BZA13264
- Expiration date of the lot/batch: 23 June 2018
- Manufacturingt date: 23 April 2018
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature under nitrogen
- Not stable at higher temperatures
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: No correction was made for the purity/composition of the test item. A solubility test was performed based on visual assessment. The test item formed a clear colourless solution in DMSO. Test item concentrations were used within 2 hours after preparation.
- Final dilution of a dissolved solid, stock liquid or gel: dilutions of the test item where prepared using DMSO as vehicle.
FORM AS APPLIED IN THE TEST (if different from that of starting material) : diluted in DMSO. - Target gene:
- Histidine locus and tryptophan locus
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Trinova Biochem GmbH
- Suitability of cells: The Salmonella typhimurium strains were checked at least every year to confirm their histidine-requirement, crystal violet sensitivity, ampicillin resistance (TA98 and TA100), UV-sensitivity and the number of spontaneous revertants.
MEDIA USED
- Type and identity of media: Agar plates (ø 9 cm) contained 25 mL glucose agar medium. Glucose agar medium contained per liter: 18 g purified agar (Oxoid LTD) in Vogel-Bonner Medium E, 20 g glucose (Fresenius Kabi, Bad Homburg, Germany). The agar plates for the test with the Salmonella typhimurium strains also contained 12.5 μg/plate biotin (Merck) and 15 μg/plate histidine (Sigma). - Additional strain / cell type characteristics:
- other:
- Remarks:
- deep rough, mutation in the galactose metabolism, mutation in nitrate reductase, defective biotin synthesis, loss of the excision repair system
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells:
Trinova Biochem GmbH
- Suitability of cells: The Escherichia coli strain was checked to confirm the tryptophan requirement, UV-sensitivity and the number of spontaneous revertants at least every year.
MEDIA USED
- Type and identity of media: Agar plates (ø 9 cm) contained 25 mL glucose agar medium. Glucose agar medium contained per liter: 18 g purified agar (Oxoid LTD) in Vogel-Bonner Medium E, 20 g glucose (Fresenius Kabi, Bad Homburg, Germany). The agar plates for the test with the Escherichia coli strain contained 15 μg/plate tryptophan (Sigma). - Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes (S9 homogenate) prepared from male Sprague Dawley rats that had been injected intraperitoneally with Aroclor 1254 (500 mg/kg body weight).
- Test concentrations with justification for top dose:
- Dose-range finding test: Selection of an adequate range of doses was based on a dose-range finding test with the strains TA100 and WP2uvrA, both with and without S9-mix. Eight concentrations, 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 μg/plate were tested in triplicate. The highest concentration of Thio Isocyanate Adduct used in the subsequent mutation assays was 5000 μg/plate or the level at which the test item inhibited bacterial growth.
First experiment - direct plate assay: The dose-range finding study with two tester strains is reported as a part of the direct plate assay. In the second part of this experiment, the test item was tested at 5.4, 17, 52, 164, 512, and 1000 ug/plate. Initially in tester strains TA1535 and TA98 no dose level with precipitation and/or cytotoxicity was tested in the presence of S9-mix. Therefore an additional experiment was performed at 1600 and 5000 ug/plate with these tester strain in presence of S9-mix to complete the data. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- methylmethanesulfonate
- other: ICR-191 ; 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (direct plate incorporation and preincubation)
- Cell density at seeding (if applicable): 1 mL (10 EXP 9 cells/mL) added to 3.6 mL medium with test item.
DURATION
- Preincubation period: when applicable, 30 +/- 2 minutes
- Exposure duration: 48 +/- 4 h
NUMBER OF REPLICATIONS: 3
- OTHER: Colony counting: The revertant colonies were counted automatically with the Sorcerer Colony Counter. Plates with sufficient test item precipitate to interfere with automated colony counting were counted manually. Evidence of test item precipitate on the plates and the condition of the bacterial background lawn were evaluated when considered necessary, macroscopically and/or microscopically by using a dissecting microscope. - Rationale for test conditions:
- Recommended test system in international guidelines
- Evaluation criteria:
- In addition to the criteria stated below, any increase in the total number of revertants should be evaluated for its biological relevance including a comparison of the results with the historical control data range.
A test item is considered negative (not mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537 or TA98 is not greater than three (3) times the concurrent control.
b) The negative response should be reproducible in at least one follow up experiment.
A test item is considered positive (mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 or WP2uvrA is greater than two (2) times the concurrent control, or the total number of revertants in tester strains TA1535, TA1537 or TA98 is greater than three (3) times the concurrent control.
b) In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one follow up experiment. - Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate in the absence of S9-mix and at 1600 µg/plate and upwards in the presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate in the absence of S9-mix and at 1600 µg/plate and upwards in the presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate in the absence of S9-mix and at 1600 µg/plate and upwards in the presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate in the absence of S9-mix and at 1600 µ/plate and upwards in the presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 1000 µg/plate in the absence of S9-mix and at 1600 µg/plate and upwards in the presence of S9-mix
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Evidence of test item precipitate on the plates is recorded by addition of the following precipitation definition:
Slight precipitate: Distinguished by noticeable precipitate on the plate. However, the precipitate does not influence automated counting of the plate.
Moderate precipitate: Distinguished by a marked amount of precipitate on the plate, requiring the plate to be hand counted.
Heavy precipitate: Distinguished by a large amount of precipitate on the plate, making the required hand count difficult.
In the dose-range finding study, the test item precipitated on the plates at the highest dose level tested (1600 µ/plate and upwards at the start of th incubation period and at 5000 µg/plate at the end of the incubation period). In the pre-incubation assay, precipitation of the test substance was observed at the start of the incubation period at 1600 and 5000 µg/plate and no precipitate was observed at the end of the incubation period.
RANGE-FINDING/SCREENING STUDIES: Thio Isocyanate Adduct was initially tested in the tester strains TA100 and WP2uvrA as a dose-range finding test with concentrations of 1.7, 5.4, 17, 52, 164, 512, 1600 and 5000 μg/plate in the absence and presence of S9-mix.
Based on the results of the dose-range finding test, a dose-range was selected for the first mutation assay with tester strains TA1535, TA1537 and TA98 in the absence and presence of S9-mix: 5.4, 17, 52, 164, 512, and 1000 μg/plate.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: decrease in the number of revertants and/or reduction of the bacterial background lawn. - Remarks on result:
- other:
- Remarks:
- Precipitation observed at the start of the incubation period at 1600 µ/plate and upwards and at 5000 µg/plate at the end of the incubation period
- Conclusions:
- Based on the results of this study it is concluded that Thio Isocyanate Adduct is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
- Executive summary:
The objective of the study was to determine the potential of Thio Isocyanate Adduct and/or its metabolites to induce reverse mutations at the histidine locus in several strains of Salmonella typhimurium (S. typhimurium; TA98, TA100, TA1535, and TA1537), and at the tryptophan locus of Escherichia coli (E. coli) strain WP2uvrA in the presence or absence of an exogenous mammalian metabolic activation system (S9).
The test was performed in two independent experiments, at first a direct plate assay was performed and secondly a pre-incubation assay.
In the dose-range finding study, the test item was initially tested up to concentrations of 5000 μg/plate in the strains TA100 and WP2uvrA in the direct plate assay. Thio Isocyanate Adduct precipitated on the plates at the highest dose level tested. Cytotoxicity, as evidenced by a decrease in the number of revertants and/or a reduction of the bacterial background lawn, was observed in both tester strains in the absence and presence of S9-mix. Results of this dose-range finding test were reported as part of the first mutation assay.
In the first mutation experiment, the test item was tested up to concentrations of 1000 μg/plate in the strains TA1535, TA98 and TA1537. Except for tester strains TA1535 and TA98 in the presence of S9-mix where the test item was tested up to concentrations of 1600 μg/plate. Thio Isocyanate Adduct did not precipitate on the plates at this dose level.
Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix.
In the second mutation experiment, the test item was tested up to concentrations of 1600 μg/plate in the tester strains TA1535, TA1537, TA98 and TA100 and up to concentrations of 5000 μg/plate in tester strain WP2uvrA in the pre-incubation assay. Thio Isocyanate Adduct did not precipitate on the plates at this dose level. Cytotoxicity, as evidenced by a decrease in the number of revertants, reduction of the bacterial background lawn and/or the presence of microcolonies, was observed in all tester strains in the absence and presence of S9-mix.
Acceptable responses were obtained for the negative and strain-specific positive control items indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
The test item did not induce a significant dose-related increase in the number of revertant (His+) colonies in each of the four tester strains (TA1535, TA1537, TA98 and TA100) and in the number of revertant (Trp+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. These results were confirmed in a follow-up experiment.
In conclusion, based on the results of this study it is concluded that Thio Isocyanate Adduct is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
Reference
Historical control data of the solvent control:
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
S-9 mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Range |
3-29 |
3-27 |
3-20 |
3-23 |
8-41 |
8-55 |
61-176 |
60-160 |
10-59 |
9-67 |
Mean |
10 |
11 |
6 |
6 |
16 |
22 |
110 |
106 |
26 |
33 |
SD |
3 |
4 |
2 |
3 |
5 |
7 |
17 |
20 |
6 |
8 |
n |
2458 |
2426 |
2402 |
2352 |
2416 |
2458 |
2473 |
2398 |
2237 |
2217 |
Historical control data of the positive control items:
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
S-9 mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Range |
128-1530 |
73-1206 |
58-1407 |
54-1051 |
365-1978 |
250-1977 |
439-1993 |
408-2379 |
93-1958 |
111-1359 |
Mean |
901 |
239 |
817 |
340 |
1355 |
903 |
905 |
1249 |
1059 |
444 |
SD |
174 |
115 |
354 |
160 |
230 |
357 |
163 |
371 |
506 |
144 |
n |
2400 |
2296 |
2051 |
2337 |
2357 |
2367 |
2402 |
2354 |
2153 |
2232 |
Direct plate assay – Mean number of revertant colonies:
|
TA1535 |
TA1537 |
TA98 |
|||
Dose (µg/plate) S9-mix |
- |
+ |
- |
+ |
- |
+ |
Positive control |
1306 |
399 |
830 |
384 |
1220 |
1227 |
Solvent control |
13 |
12 |
5 |
10 |
13 |
16 |
5.4 |
12 |
14 |
4 |
4 |
12 |
23 |
17 |
10 |
12 |
4 |
4 |
12 |
12 |
52 |
6 |
12 |
3 |
5 |
6 |
16 |
164 |
10 |
9 |
4 |
3 |
8 |
13 |
512 |
13 |
11 |
1 |
4 |
12 |
13 |
1000 |
9 |
10 |
2 |
2 |
13 |
12 |
Pre-incubation assay – Mean number of revertant colonies:
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
Dose (µg/plate) S9-mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Positive control |
1144 |
238 |
175 |
243 |
1342 |
718 |
784 |
1931 |
275 |
567 |
Solvent control |
18 |
16 |
14 |
13 |
28 |
42 |
107 |
133 |
31 |
45 |
5.4 |
18 |
13 |
8 |
8 |
24 |
31 |
124 |
116 |
- |
- |
17 |
11 |
15 |
13 |
12 |
35 |
33 |
116 |
130 |
37 |
49 |
52 |
13 |
12 |
9 |
13 |
28 |
32 |
115 |
105 |
38 |
51 |
164 |
14 |
14 |
6 |
10 |
29 |
35 |
103 |
161 |
35 |
39 |
512 |
|
13 |
|
|
|
37 |
|
106 |
36 |
35 |
1000 |
|
|
|
|
|
|
|
|
22 |
36 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Thio Isocyanate Adduct has been tested for mutagenicity to bacteria, in a study that was conducted according to the OECD TG 471 and in compliance with GLP. The test item did not induce a significant dose-related increase in the number of revertant (His+) colonies in each of the four tester strains (TA1535, TA1537, TA98 and TA100) and in the number of revertant (Trp+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. These results were confirmed in a follow-up experiment. Based on the results of this study it is concluded that Thio Isocyanate Adduct is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
Justification for classification or non-classification
Based on the available in vitro genotoxicity data, Thio Isocyanate Adduct is not classified for mutagenicity according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)